Eli Lilly and Co. could pay more than $570 million to French pharmaceutical company Adocia under an agreement to develop a fast-acting insulin that is in the early stages of clinical testing. … Click to Continue »
Business News | Miami Herald & MiamiHerald.com, Miami Herald: Business
Fri, 12/19/2014 - 5:20am
Eli Lilly and Co. could pay more than $570 million to French pharmaceutical company Adocia under an agreement to develop a fast-acting insulin that is in the early stages of clinical testing. … Click to Continue »